Research and experimental development on natural sciences and engineering
CALLUNA PHARMA AS
Incorporated
2023
Employees
10
Share capital
NOK 1.0m
Roles
Daglig lederMark William-Semrau Gaffney
Regnskapsfører
Revisor
Styrets lederMark Frederick Altmeyer
StyremedlemSusanne Stuffers
StyremedlemFarzad Abdi-Dezfuli
StyremedlemMarco Boorsma
StyremedlemMark William-Semrau Gaffney
StyremedlemGijs Robert Van Den Brink
Auditor
Audit firm
BJØRGVIN REVISJON AS
12 registrerte revisorer ved BJØRGVIN REVISJON AS:
ARILD FALCHStatsautorisert revisor
ARVE HORDVIKStatsautorisert revisor
CECILIE LANGELAND BERGStatsautorisert revisor
JARLE SOLDALStatsautorisert revisor
JØRGEN LUND JANSENStatsautorisert revisor
LINA VARTDALStatsautorisert revisor
METTE FAVANGStatsautorisert revisor
NIKLAS RENE NYBERGStatsautorisert revisor
RUNE MYHRE ROSVOLDStatsautorisert revisor
STINE FJELDSBØ LUNDBERGStatsautorisert revisor
SVEIN KENNETH HØGEMARKStatsautorisert revisor
TOM MAGNE DAHLSTRØMStatsautorisert revisor
The Brønnøysund registers name the audit firm, not which individual auditor signs the accounts.
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| CALLUNA PHARMA POOLCO AS | 34.9% | 36321541.000000 | 2025 |
| FORBION VENTURES FUND VI COOPERATIV | 24.1% | 25151515.000000 | 2025 |
| FORCAL I INVESTMENT FUND | 19.9% | 20693939.000000 | 2025 |
| FORBION CAPITAL FUND IV COOPERATIEF | 16.7% | 17422185.000000 | 2025 |
| STITCHING ADMINISTRATIEKANTOOR OXIT | 3.3% | 3463451.000000 | 2025 |
| CALLUNA PHARMA POOLCO AS | 0.7% | 687056.000000 | 2025 |
| CALLUNA PHARMA POOLCO AS | 0.4% | 427308.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| ARXX THERAPEUTICS AS | Active | 100.0% | 26043511.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.